Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1155320

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1155320

Europe 3D Cell Culture Market Size, Share & Industry Trends Analysis Report By Type (Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinted), By Application, By End User, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 93 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe 3D Cell Culture Market would witness market growth of 15.2% CAGR during the forecast period (2022-2028).

3D cell cultures are more stable as well as have extended lifespans in contrast to 2D cell cultures. This indicates that they are better ideal for long-term trials and demonstrating the drug's long-term effects. Additionally, 3D surroundings allow cells to grow undisturbed. In 2D, cells must be regularly trypsinized in order to receive enough nutrients for optimal cell development.

Three-dimensional spheroids have been cultivated in the laboratory for up to 302 days while sustaining healthy, noncancerous development. Preclinical testing of the pharmacokinetic and pharmacodynamic effects of medicines and nanomaterials is the main objective of growing cells in 3D scaffolds and also as 3D cell spheroids in vitro.

Toxicology studies have demonstrated that 3D cell cultures are comparable to in vivo studies for assessing the toxicity of medicinal molecules. When comparing LD50 values for six common medications, diclofenac, acetaminophen, amiodarone, metformin, phenformin, and valproic acid, 3D spheroid values correlated directly with in vivo study values.

The industry of research and development in European nations is substantial. Europe comprises 21 OECD countries that are also members of the European Union, as well as Iceland, Norway, and Switzerland, according to the Organization for Economic Co-operation and Development Library. The government's funding for research and development, or GBARD, encompasses both the government's direct R&D and the sums allocated to other institutions for R&D.

The Germany market dominated the Europe 3D Cell Culture Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $212.4 million by 2028. The UK market is anticipated to grow at a CAGR of 14.3% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 16% during (2022 - 2028).

Based on Type, the market is segmented into Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinted. Based on Application, the market is segmented into Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing, and Tissue Engineering & Regenerative Medicine. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Research Institutes, Cosmetic Industry, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, Avantor, Inc., Corning Incorporated, Lonza Group AG, Mimetas B.V., Insphero AG, Emulate, Inc., Tecan Group Ltd., and CN Bio Innovations Ltd.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Scaffold-based
  • Scaffold-free
  • Microfluidics-based
  • Magnetic & Bioprinted

By Application

  • Cancer & Stem Cell Research
  • Drug Discovery & Toxicology Testing
  • Tissue Engineering & Regenerative Medicine

By End User

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Cosmetic Industry
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Merck Group
  • Avantor, Inc.
  • Corning Incorporated
  • Lonza Group AG
  • Mimetas B.V.
  • Insphero AG
  • Emulate, Inc.
  • Tecan Group Ltd.
  • CN Bio Innovations Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe 3D Cell Culture Market, by Type
    • 1.4.2 Europe 3D Cell Culture Market, by Application
    • 1.4.3 Europe 3D Cell Culture Market, by End User
    • 1.4.4 Europe 3D Cell Culture Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition and scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Geographical Expansion
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2018, May - 2022, Oct) Leading Players
    • 3.3.3 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun - 2022, Jun) Leading Players

Chapter 4. Europe 3D Cell Culture Market by Type

  • 4.1 Europe Scaffold-based Market by Country
  • 4.2 Europe Scaffold-free Market by Country
  • 4.3 Europe Microfluidics-based Market by Country
  • 4.4 Europe Magnetic & Bioprinted Market by Country

Chapter 5. Europe 3D Cell Culture Market by Application

  • 5.1 Europe Cancer & Stem Cell Research Market by Country
  • 5.2 Europe Drug Discovery & Toxicology Testing Market by Country
  • 5.3 Europe Tissue Engineering & Regenerative Medicine Market by Country

Chapter 6. Europe 3D Cell Culture Market by End User

  • 6.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
  • 6.2 Europe Research Institutes Market by Country
  • 6.3 Europe Cosmetic Industry Market by Country
  • 6.4 Europe Others Market by Country

Chapter 7. Europe 3D Cell Culture Market by Country

  • 7.1 Germany 3D Cell Culture Market
    • 7.1.1 Germany 3D Cell Culture Market by Type
    • 7.1.2 Germany 3D Cell Culture Market by Application
    • 7.1.3 Germany 3D Cell Culture Market by End User
  • 7.2 UK 3D Cell Culture Market
    • 7.2.1 UK 3D Cell Culture Market by Type
    • 7.2.2 UK 3D Cell Culture Market by Application
    • 7.2.3 UK 3D Cell Culture Market by End User
  • 7.3 France 3D Cell Culture Market
    • 7.3.1 France 3D Cell Culture Market by Type
    • 7.3.2 France 3D Cell Culture Market by Application
    • 7.3.3 France 3D Cell Culture Market by End User
  • 7.4 Russia 3D Cell Culture Market
    • 7.4.1 Russia 3D Cell Culture Market by Type
    • 7.4.2 Russia 3D Cell Culture Market by Application
    • 7.4.3 Russia 3D Cell Culture Market by End User
  • 7.5 Spain 3D Cell Culture Market
    • 7.5.1 Spain 3D Cell Culture Market by Type
    • 7.5.2 Spain 3D Cell Culture Market by Application
    • 7.5.3 Spain 3D Cell Culture Market by End User
  • 7.6 Italy 3D Cell Culture Market
    • 7.6.1 Italy 3D Cell Culture Market by Type
    • 7.6.2 Italy 3D Cell Culture Market by Application
    • 7.6.3 Italy 3D Cell Culture Market by End User
  • 7.7 Rest of Europe 3D Cell Culture Market
    • 7.7.1 Rest of Europe 3D Cell Culture Market by Type
    • 7.7.2 Rest of Europe 3D Cell Culture Market by Application
    • 7.7.3 Rest of Europe 3D Cell Culture Market by End User

Chapter 8. Company Profiles

  • 8.1 Thermo Fisher Scientific, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Product Launches and Product Expansions:
      • 8.1.5.2 Acquisition and Mergers:
      • 8.1.5.3 Geographical Expansions:
  • 8.2 Merck Group
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Partnerships, Collaborations, and Agreements:
  • 8.3 Avantor, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Recent strategies and developments:
      • 8.3.4.1 Partnerships, Collaborations, and Agreements:
      • 8.3.4.2 Acquisition and Mergers:
  • 8.4 Corning Incorporated
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Product Launches and Product Expansions:
  • 8.5 Lonza Group AG
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Geographical Expansions:
  • 8.6 Mimetas B.V.
    • 8.6.1 Company Overview
    • 8.6.2 Recent strategies and developments:
      • 8.6.2.1 Product Launches and Product Expansions:
  • 8.7 Insphero AG
    • 8.7.1 Company Overview
    • 8.7.2 Recent strategies and developments:
      • 8.7.2.1 Partnerships, Collaborations, and Agreements:
      • 8.7.2.2 Product Launches and Product Expansions:
  • 8.8 Emulate, Inc.
    • 8.8.1 Company Overview
  • 8.9 Tecan Group Ltd.
    • 8.9.1 Company Overview
  • 8.10. CN Bio Innovations Ltd.
    • 8.10.1 Company Overview
    • 8.10.2 Recent strategies and developments:
      • 8.10.2.1 Partnerships, Collaborations, and Agreements:
      • 8.10.2.2 Product Launches and Product Expansions:
      • 8.10.2.3 Geographical Expansions:

LIST OF TABLES

  • TABLE 1 Europe 3D Cell Culture Market, 2018 - 2021, USD Million
  • TABLE 2 Europe 3D Cell Culture Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- 3D Cell Culture Market
  • TABLE 4 Product Launches And Product Expansions- 3D Cell Culture Market
  • TABLE 5 Acquisition and Mergers- 3D Cell Culture Market
  • TABLE 6 Geographical Expansion- 3D Cell Culture Market
  • TABLE 7 Europe 3D Cell Culture Market by Type, 2018 - 2021, USD Million
  • TABLE 8 Europe 3D Cell Culture Market by Type, 2022 - 2028, USD Million
  • TABLE 9 Europe Scaffold-based Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Europe Scaffold-based Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Europe Scaffold-free Market by Country, 2018 - 2021, USD Million
  • TABLE 12 Europe Scaffold-free Market by Country, 2022 - 2028, USD Million
  • TABLE 13 Europe Microfluidics-based Market by Country, 2018 - 2021, USD Million
  • TABLE 14 Europe Microfluidics-based Market by Country, 2022 - 2028, USD Million
  • TABLE 15 Europe Magnetic & Bioprinted Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Europe Magnetic & Bioprinted Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Europe 3D Cell Culture Market by Application, 2018 - 2021, USD Million
  • TABLE 18 Europe 3D Cell Culture Market by Application, 2022 - 2028, USD Million
  • TABLE 19 Europe Cancer & Stem Cell Research Market by Country, 2018 - 2021, USD Million
  • TABLE 20 Europe Cancer & Stem Cell Research Market by Country, 2022 - 2028, USD Million
  • TABLE 21 Europe Drug Discovery & Toxicology Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 22 Europe Drug Discovery & Toxicology Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 23 Europe Tissue Engineering & Regenerative Medicine Market by Country, 2018 - 2021, USD Million
  • TABLE 24 Europe Tissue Engineering & Regenerative Medicine Market by Country, 2022 - 2028, USD Million
  • TABLE 25 Europe 3D Cell Culture Market by End User, 2018 - 2021, USD Million
  • TABLE 26 Europe 3D Cell Culture Market by End User, 2022 - 2028, USD Million
  • TABLE 27 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 28 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 29 Europe Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 30 Europe Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 31 Europe Cosmetic Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 32 Europe Cosmetic Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 33 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 34 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 35 Europe 3D Cell Culture Market by Country, 2018 - 2021, USD Million
  • TABLE 36 Europe 3D Cell Culture Market by Country, 2022 - 2028, USD Million
  • TABLE 37 Germany 3D Cell Culture Market, 2018 - 2021, USD Million
  • TABLE 38 Germany 3D Cell Culture Market, 2022 - 2028, USD Million
  • TABLE 39 Germany 3D Cell Culture Market by Type, 2018 - 2021, USD Million
  • TABLE 40 Germany 3D Cell Culture Market by Type, 2022 - 2028, USD Million
  • TABLE 41 Germany 3D Cell Culture Market by Application, 2018 - 2021, USD Million
  • TABLE 42 Germany 3D Cell Culture Market by Application, 2022 - 2028, USD Million
  • TABLE 43 Germany 3D Cell Culture Market by End User, 2018 - 2021, USD Million
  • TABLE 44 Germany 3D Cell Culture Market by End User, 2022 - 2028, USD Million
  • TABLE 45 UK 3D Cell Culture Market, 2018 - 2021, USD Million
  • TABLE 46 UK 3D Cell Culture Market, 2022 - 2028, USD Million
  • TABLE 47 UK 3D Cell Culture Market by Type, 2018 - 2021, USD Million
  • TABLE 48 UK 3D Cell Culture Market by Type, 2022 - 2028, USD Million
  • TABLE 49 UK 3D Cell Culture Market by Application, 2018 - 2021, USD Million
  • TABLE 50 UK 3D Cell Culture Market by Application, 2022 - 2028, USD Million
  • TABLE 51 UK 3D Cell Culture Market by End User, 2018 - 2021, USD Million
  • TABLE 52 UK 3D Cell Culture Market by End User, 2022 - 2028, USD Million
  • TABLE 53 France 3D Cell Culture Market, 2018 - 2021, USD Million
  • TABLE 54 France 3D Cell Culture Market, 2022 - 2028, USD Million
  • TABLE 55 France 3D Cell Culture Market by Type, 2018 - 2021, USD Million
  • TABLE 56 France 3D Cell Culture Market by Type, 2022 - 2028, USD Million
  • TABLE 57 France 3D Cell Culture Market by Application, 2018 - 2021, USD Million
  • TABLE 58 France 3D Cell Culture Market by Application, 2022 - 2028, USD Million
  • TABLE 59 France 3D Cell Culture Market by End User, 2018 - 2021, USD Million
  • TABLE 60 France 3D Cell Culture Market by End User, 2022 - 2028, USD Million
  • TABLE 61 Russia 3D Cell Culture Market, 2018 - 2021, USD Million
  • TABLE 62 Russia 3D Cell Culture Market, 2022 - 2028, USD Million
  • TABLE 63 Russia 3D Cell Culture Market by Type, 2018 - 2021, USD Million
  • TABLE 64 Russia 3D Cell Culture Market by Type, 2022 - 2028, USD Million
  • TABLE 65 Russia 3D Cell Culture Market by Application, 2018 - 2021, USD Million
  • TABLE 66 Russia 3D Cell Culture Market by Application, 2022 - 2028, USD Million
  • TABLE 67 Russia 3D Cell Culture Market by End User, 2018 - 2021, USD Million
  • TABLE 68 Russia 3D Cell Culture Market by End User, 2022 - 2028, USD Million
  • TABLE 69 Spain 3D Cell Culture Market, 2018 - 2021, USD Million
  • TABLE 70 Spain 3D Cell Culture Market, 2022 - 2028, USD Million
  • TABLE 71 Spain 3D Cell Culture Market by Type, 2018 - 2021, USD Million
  • TABLE 72 Spain 3D Cell Culture Market by Type, 2022 - 2028, USD Million
  • TABLE 73 Spain 3D Cell Culture Market by Application, 2018 - 2021, USD Million
  • TABLE 74 Spain 3D Cell Culture Market by Application, 2022 - 2028, USD Million
  • TABLE 75 Spain 3D Cell Culture Market by End User, 2018 - 2021, USD Million
  • TABLE 76 Spain 3D Cell Culture Market by End User, 2022 - 2028, USD Million
  • TABLE 77 Italy 3D Cell Culture Market, 2018 - 2021, USD Million
  • TABLE 78 Italy 3D Cell Culture Market, 2022 - 2028, USD Million
  • TABLE 79 Italy 3D Cell Culture Market by Type, 2018 - 2021, USD Million
  • TABLE 80 Italy 3D Cell Culture Market by Type, 2022 - 2028, USD Million
  • TABLE 81 Italy 3D Cell Culture Market by Application, 2018 - 2021, USD Million
  • TABLE 82 Italy 3D Cell Culture Market by Application, 2022 - 2028, USD Million
  • TABLE 83 Italy 3D Cell Culture Market by End User, 2018 - 2021, USD Million
  • TABLE 84 Italy 3D Cell Culture Market by End User, 2022 - 2028, USD Million
  • TABLE 85 Rest of Europe 3D Cell Culture Market, 2018 - 2021, USD Million
  • TABLE 86 Rest of Europe 3D Cell Culture Market, 2022 - 2028, USD Million
  • TABLE 87 Rest of Europe 3D Cell Culture Market by Type, 2018 - 2021, USD Million
  • TABLE 88 Rest of Europe 3D Cell Culture Market by Type, 2022 - 2028, USD Million
  • TABLE 89 Rest of Europe 3D Cell Culture Market by Application, 2018 - 2021, USD Million
  • TABLE 90 Rest of Europe 3D Cell Culture Market by Application, 2022 - 2028, USD Million
  • TABLE 91 Rest of Europe 3D Cell Culture Market by End User, 2018 - 2021, USD Million
  • TABLE 92 Rest of Europe 3D Cell Culture Market by End User, 2022 - 2028, USD Million
  • TABLE 93 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 94 key Information - Merck GrouP
  • TABLE 95 Key Information - Avantor, Inc.
  • TABLE 96 Key Information - Corning Incorporated
  • TABLE 97 Key Information - Lonza Group AG
  • TABLE 98 Key Information - Mimetas B.V.
  • TABLE 99 Key Information - Insphero AG
  • TABLE 100 Key Information - Emulate, Inc.
  • TABLE 101 Key Information - Tecan Group Ltd.
  • TABLE 102 Key Information - CN Bio Innovations Ltd.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, May - 2022, Oct) Leading Players
  • FIG 5 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun - 2022, Jun) Leading Players
  • FIG 6 Recent strategies and developments: Thermo Fisher Scientific, Inc.
  • FIG 7 Recent strategies and developments: Avantor, Inc.
  • FIG 8 Recent strategies and developments: Lonza Group AG
  • FIG 9 Recent strategies and developments: Insphero AG
  • FIG 10 Recent strategies and developments: CN Bio Innovations Limited
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!